BETHANECHOL CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bethanechol Chloride, and what generic alternatives are available?
Bethanechol Chloride is a drug marketed by Able, Actavis Elizabeth, Amneal Pharm, Ascot, Chartwell Rx, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Co Inc, Sandoz, Sun Pharm Inds Inc, Upsher Smith Labs, Watson Labs, and Wockhardt. and is included in forty-four NDAs.
The generic ingredient in BETHANECHOL CHLORIDE is bethanechol chloride. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bethanechol Chloride
A generic version of BETHANECHOL CHLORIDE was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
Summary for BETHANECHOL CHLORIDE
US Patents: | 0 |
Applicants: | 15 |
NDAs: | 44 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Clinical Trials: | 1 |
Patent Applications: | 1,469 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BETHANECHOL CHLORIDE at DailyMed |
Recent Clinical Trials for BETHANECHOL CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rajavithi Hospital | Phase 4 |
Pharmacology for BETHANECHOL CHLORIDE
Drug Class | Cholinergic Muscarinic Agonist |
Mechanism of Action | Cholinergic Muscarinic Agonists |